EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Focused ultrasound-assisted delivery of immunomodulating agents in brain cancer

Elahe Memari, Dure Khan, Ryan Alkins, Brandon Helfield

Journal of Controlled Release · 2024-03 · 367 · 283-299

DOI: 10.1016/j.jconrel.2024.01.034 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2024-03. Verfasst von Elahe Memari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, Concordia University, Montreal H4B 1R6, Canada. Hauptthemen laut MEDLINE: Immunomodulating Agents, Brain Neoplasms. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 222 Literaturangaben. Gefördert von: Cancer Research Society, Canadian Aeronautics and Space Institute, Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Focused ultrasound (FUS) combined with intravascularly circulating microbubbles can transiently increase the permeability of the blood-brain barrier (BBB) to enable targeted therapeutic delivery to the brain, the clinical testing of which is currently underway in both adult and pediatric patients. Aside from traditional cancer drugs, this technique is being extended to promote the delivery of immunomodulating therapeutics to the brain, including antibodies, immune cells, and cytokines. In this manner, FUS approaches are being explored as a tool to improve and amplify the effectiveness of immunotherapy for both primary and metastatic brain cancer, a particularly challenging solid tumor to treat. Here, we present an overview of the latest groundbreaking research in FUS-assisted delivery of immunomodulating agents to the brain in pre-clinical models of brain cancer, and place it within the context of the current immunotherapy approaches. We follow this up with a discussion on new developments and emerging strategies for this rapidly evolving approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunomodulating AgentsBrain NeoplasmsHumansChildDrug Delivery SystemsBlood-Brain BarrierBrainMicrobubblesMagnetic Resonance Imaging

Stichwörter der Autor:innen

Blood-brain-barrier openingCavitationImmunotherapyMicrobubblesSonoporation

Substanzen

Immunomodulating Agents

Autor:innen und Institutionen

  • Department of Physics, Concordia University, Montreal H4B 1R6, Canada.
  • Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada.
  • Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada; Division of Neurosurgery, Department of Surgery, Kingston Health Sciences Centre, Queen's University, Kingston, ON, Canada.
  • Department of Physics, Concordia University, Montreal H4B 1R6, Canada; Department of Biology, Concordia University, Montreal H4B 1R6, Canada. Electronic address: brandon.hefield@concordia.ca.

Förderung

  • Cancer Research Society
  • Canadian Aeronautics and Space Institute
  • Natural Sciences and Engineering Research Council of Canada
  • Canada Research Chairs
  • Burroughs Wellcome Fund

Zitieren

APA

Memari, E., Khan, D., Alkins, R., & Helfield, B. (2024). Focused ultrasound-assisted delivery of immunomodulating agents in brain cancer. Journal of Controlled Release, 367, 283-299. https://doi.org/10.1016/j.jconrel.2024.01.034

Vancouver

Memari E, Khan D, Alkins R, Helfield B. Focused ultrasound-assisted delivery of immunomodulating agents in brain cancer. Journal of Controlled Release. 2024;367:283-299. doi:10.1016/j.jconrel.2024.01.034

BibTeX
@article{Memari2024,
  author = {Memari, Elahe and Khan, Dure and Alkins, Ryan and Helfield, Brandon},
  title = {Focused ultrasound-assisted delivery of immunomodulating agents in brain cancer},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {367},
  pages = {283--299},
  doi = {10.1016/j.jconrel.2024.01.034}
}
Kostenlos starten →